These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12204666)

  • 41. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
    Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.
    Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B;
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial.
    Erlandsson J; Holm T; Pettersson D; Berglund Å; Cedermark B; Radu C; Johansson H; Machado M; Hjern F; Hallböök O; Syk I; Glimelius B; Martling A
    Lancet Oncol; 2017 Mar; 18(3):336-346. PubMed ID: 28190762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeat CT assessed CTV variation and PTV margins for short- and long-course pre-operative RT of rectal cancer.
    Nijkamp J; Swellengrebel M; Hollmann B; de Jong R; Marijnen C; van Vliet-Vroegindeweij C; van Triest B; van Herk M; Sonke JJ
    Radiother Oncol; 2012 Mar; 102(3):399-405. PubMed ID: 22239865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
    Sauer R; Rödel C
    Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Male gonadal dose in adjuvant 3-d-pelvic irradiation after anterior resection of rectal cancer. Influence to fertility].
    Piroth MD; Hensley F; Wannenmacher M; Zierhut D
    Strahlenther Onkol; 2003 Nov; 179(11):754-9. PubMed ID: 14605745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?
    Bauduceau O; Bollet MA; Pons P; Kirova YM; Fayolle M; Zervoudis S; Campana F
    J BUON; 2008; 13(2):245-51. PubMed ID: 18555473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
    Koelbl O; Richter S; Flentje M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PET-CT fusion in radiation management of patients with anorectal tumors.
    Anderson C; Koshy M; Staley C; Esiashvili N; Ghavidel S; Fowler Z; Fox T; Esteves F; Landry J; Godette K
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):155-62. PubMed ID: 17707268
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.
    Bosset JF; Magnin V; Maingon P; Mantion G; Pelissier EP; Mercier M; Chaillard G; Horiot JC
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):323-7. PubMed ID: 10661338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study of set up variations and bowel volumes in supine versus prone positions of patients treated with external beam radiation for carcinoma rectum.
    Rajeev KR; Menon SS; Beena K; Holla R; Kumar RR; Dinesh M
    J Cancer Res Ther; 2014; 10(4):937-41. PubMed ID: 25579532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma: the dummy run.
    Davis JB; Reiner B; Dusserre A; Giraud JY; Bolla M;
    Radiother Oncol; 2002 Jul; 64(1):65-73. PubMed ID: 12208577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I--III breast cancer(1).
    Poortmans PM; Venselaar JL; Struikmans H; Hurkmans CW; Davis JB; Huyskens D; van Tienhoven G; Vlaun V; Lagendijk JJ; Mijnheer BJ; De Winter KA; Van der Hulst MH; Van den Bogaert WF
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1399-408. PubMed ID: 11286848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modelling the variation in rectal dose due to inter-fraction rectal wall deformation in external beam prostate treatments.
    Booth J; Zavgorodni S
    Phys Med Biol; 2005 Nov; 50(21):5055-74. PubMed ID: 16237241
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
    BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective MRI-based imaging study to assess feasibility of proton therapy for post-prostatectomy radiation.
    Swisher-McClure S; Yin L; Rosen M; Batra S; Berman AT; Both S; Vapiwala N
    Acta Oncol; 2016 Jul; 55(7):828-33. PubMed ID: 27145164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality assurance of the EORTC radiotherapy trial 22863 for prostatic cancer: the dummy run.
    Dusserre A; Garavaglia G; Giraud JY; Bolla M
    Radiother Oncol; 1995 Sep; 36(3):229-34. PubMed ID: 8532911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.